SCIENION AG and BioVendor Laboratorni medicina a.s. today announced that BioVendor is using SCIENION’s complementary product portfolio for the production and detection of immunoassays.
Dortmund and Berlin, Germany, July 8, 2013: Czech Republic Brno-based BioVendor Laboratorni medicina a.s. produces and distributes medical equipment and medical research products for international markets. In its Research & Diagnostics Products division, BioVendor focuses on developing and manufacturing in vitro diagnostic and research-use only immunoassays, antibodies and recombinant proteins. The company has begun developing its immunoassays using SCIENION’s integrated product portfolio including consumables such as sciPLEXPLATES, the sciFLEXARRAYER dispenser configured with both sciPICO and the new sciDROP NANO option, as well as the sciREADER CL for detection of assay results.
Dr. Viktor Růžička, CEO of BioVendor Laboratorni medicina a.s., comments: “Miniaturization and automation are key to our immunoassay production and the sciFLEXARRAYER has proven itself to be a state-of-the-art instrument for precise low volume liquid handling. We use it for developing new multiplex tests in microtiter plates to offer our customers cost-effective tools for parallel analytics. First application examples are multiplex IVD tests for the detection of borrelia infections as borreliosis can become a severe disease if not diagnosed early.”
Růžička also mentions another reason for choosing SCIENION technology: “We are spotting sensitive biological materials such as antigens and antibodies. Temperature is one of the factors that can have an impact of the functionality of these molecules. For us it is an important benefit of the sciFLEXARRAYER that the spotting head does not produce heat – especially as we manufacture tests in large quantities. Furthermore, SCIENION offers a cooling unit for source plates and targets.” And finally he appreciates that SCIENION provides complete solutions for the automated production and detection of immunoassays because this facilitates work flow and enables advanced performance as products optimally complement each other.
Dr. Holger Eickhoff, CEO of SCIENION AG, states: “BioVendor has become a leading manufacturer of immunoassays for a wide range of applications. The company is known for many innovative products that are unique to the market. We are very pleased that BioVendor has selected SCIENION equipment for assay development and production. From the very start of our collaboration, BioVendor utilizes almost the complete range of our integrated product portfolio. I am confident that this decision will pay off for the company.”
Please visit our newly redesigned Website: www.scienion.com Please meet us at:
AACC, July 30 – Aug 1, 2013, Houston,Texas, USA
About SCIENION AG
SCIENION AG and its US subsidiary SCIENION US, Inc. provide systems and services for the contact-free printing of biological and chemical agents for diagnostics, pharmaceutics, veterinary, plant and food analytics and research. Addressing the dynamically increasing needs for miniaturization and multiplex analyses, SCIENION offers a unique technology portfolio that has been continuously expanded over one decade. SCIENION provides flexible solutions for research and development whereas solutions for production purposes are rather customized. Systems and software are characterized by their versatility, precision and robustness. The company is a renowned specialist for ultra low volume liquid handling, particularly for the handling of precious and sensitive compounds of biological or chemical origin. SCIENION’s dispensers allow for contact-free and precise drop spotting in the pico- to micro-liter range and are optimally suited for microarray based analytics – such as for tests with DNA, oligonucleotides, peptides, proteins, antibodies, glycans or for dispensing cells onto various substrates. The company operates from two sites in Germany, Dortmund and Berlin, and has a subsidiary in New Jersey, USA.
BioVendor Laboratorni medicina a.s., through its three divisions, produces and distributes medical equipment and medical research products for international markets.
The Research & Diagnostic Products division of BioVendor focuses on the discovery, development and marketing of innovative immunodiagnostic kits and related monoclonal and polyclonal antibodies as well as recombinant and native proteins. BioVendor’s competitive advantage is its independence from external sources of antibodies and calibrators in the development of immunodiagnostics. BioVendor develops immunoassays for the detection of newly identified protein markers in samples of human or animal origin. This effort has resulted in the release of many products that are unique to the market. The development of new kits is targeted at research groups within the international scientific community as well as for clinical laboratory applications. BioVendor’s use of modern immunoassay formats has enabled high assay sensitivity, with an emphasis on superior analytical characteristics and user-friendly kit performance. R&D efforts are aimed at rapidly growing fields of interest such as obesity/metabolic syndrome/diabetes, cardiovascular physiology, renal disease and injury, bone metabolism/osteoporosis, infection/inflammation, oncology/tumor markers and more. To date, the company has developed and launched independently over 60 ELISA kits and 50 immunoassays are in the product pipeline. The kits are used in research and clinical labs of more than 60 countries including such demanding and competitive markets as the USA, EU countries and Japan. In 2012 BioVendor incorporated TEST-Line a.s. within their company division.
Phone: +49 (0)30 – 6392 1700
Fax: +49 (0)30 – 6392 1701
BioVendor Laboratorni medicina a.s.
Dr. Viktor Růžička
621 00 Brno
Phone: +420–549 124 185
Fax: +420–549 211 firstname.lastname@example.org